Prospective, randomized, and comparative study of efficacy of ivermectin, benzyl benzoate 25%, permethrin 5% and gamma benzene hexachloride 1% in the treatment of uncomplicated scabies

K. Chitra, Swathi Ratnam R., J. Sudha, G. Suryanarayana


Background: Scabies is an infectious and contagious human skin disease. The aim of the study was to study the efficacy and safety of four different treatment modalities in clinically diagnosed cases of scabies of single dose of oral ivermectin and commonly used topical scabicidal agent’s benzyl benzoate 25% (BB), permethrin 5% and gamma benzene hexachloride 1% (GBHC).

Methods: This study was carried out in the Department of Dermatology, Andhra Medical College, Visakhapatnam. 200 patients diagnosed of scabies were included in the study during the period from August 2013 to July 2014. The percentage of improvement was compared between four groups. Intergroup comparison between two groups was done Chi square test.

Results: In the present study a greater number of patients were students (54.5%). Subsidence of lesion and itching with oral ivermectin given as a single dose (200 μg/kg body weight) was 45 (90%) and 44 (88%), with topical permethrin 5% lotion single application 48 (96%), 47 (94%), with topical GBHC 1% lotion 40 (80%) patients, 38 (76%). Topical application of BB lotion 25% was 38 (76%), and 36 (72%) at fourth week.

Conclusions: In the present study permethrin 5% cream was found to be more effective among topical agents. Both BB and GBHC 1% lotion are being inexpensive and they can be used as an alternative treatment in developing country like India.


Scabies, Ivermectin, Benzyl benzoate, Permethrin and gamma benzene hexa chloride

Full Text:



Bulletin World Health Organisation (2012) Neglected tropical diseases: diseases covered by NTD department. Available:,neglected diseases/diseases/en. Accessed on 05 April 2019.

Towards the Global control of Human scabies. PLOS Neglected Tropical Diseases; August 2013/volume 7/issue 8/e2167 Accessed on 05 April 2019.

Andrew Steer IACS Blog Post on Jul 2014.

Epidemiology and management of common skin diseases in children in developing countries. Geneva: World Health Organisation; 2005.

Davis JS, Gloughlin MS, Tong SY, Walton SF, Currie BJ. A novel clinical grading scale to guide the management of crusted scabies. PLoS Negl Trop Dis. 2013;7(9):2387.

Gulati PV, Sachder TR, Varma RK. Scabies - An epidemiological study in a resettlement colony. Indian J Dermatol Verenereol Leprol. 1981;47(6):299-302.

Bedi TR. Human scabies - A continuing problem. Indian J Dermatol Verenereol Leprol. 1976;42:235-6.

Nair BK, Joseph A, Kandamutham M. Epidemic scabies. Indian J Med Res. 1977;65(4):513-8.

Hati AK, Chaudhary DSR, Gupta R. Clinico parasitological studies on scabies. J Dermatol Vereneol. 1974;40:3-4.

Usha V, Nair TV. A comparative study of oral Ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol. 2000;42:236-40.

Chouela EN, Abeldano AM, Pellerano G, Laforgian, Paple RM, Garsd A. Equivalent therapeutic efficacy and safety of Ivermectin and Lindane in the treatment of human scabies. Arch Dermatol. 1999;135:651-5.

Zargari O, Golchai J, Sobhani A, Dehpour AR, Ashkevari SS, Alizadeh N, et al. Comparison of the efficacy of topical 1% Lindane versus 5% permethrin in scabies: A randomized, double blind study. Indian J Dermatol Venereol Leprol. 2006;72:33-6.

Bachewar NP, Thawani VR, Mali SN, Gharpure KJ, Shingade VP. Comparison of safety, efficacy, and cost effectiveness of Benzyl Benzoate, Permethrin, and Ivermectin in patients of scabies. Indian J Pharmacol. 2009;41(1):9-14.

Taplin D, Meinking TL, Porcelain SL, Castillero PM, Chen JA. Permethrin 5% dermalcream: A new treatment for scabies. J Am Acad Dermatol. 1986;15:991-1001.

Glaziou P, Cartel JL, Alzieu P, Briot C, Pelat MJP, Martin PM. A Randomised investigator - blinded trial of oral ivermectin versus BB 10%. Trop med Parasitol. 1993;44(4):331-2.